In Vitro Fertilization Market Segmentation By Product (Culture Media, Incubators, Cryosystem, IVF Cabinets and Others); By End User (Hospitals, Fertility Clinics and Others) – Global Demand Analysis & Opportunity Outlook 2027

Buy Now Report ID: 2128 | Published Date: Feb 15, 2023

Growth Drivers

Increase in Infertility Rate to Propel the Market Growth

The rising awareness about various infertility treatments is resulting in a growing demand for in vitro fertilization treatment among people with infertility issues. This is predicted to significantly raise the market growth in the upcoming years. The growing cases of Polycystic Ovary Syndrome or PCOS is another key factor which leads to infertility among women and thus increases the requirement for IVF treatment procedures. According to the Centers for Disease Control and Prevention, PCOS affects around 6% to 12% of women, i.e., about 5 million women in the United States every year.

Development of Improved IVF Treatments with Higher Success Rate to Support the Market Growth

The growing number of fertility clinics is another major factor estimated to boost the market growth. According to the Fertility Clinic Success Rates Report released by CDC, around 284,385 Assisted Reproductive Technology (ART) cycles were performed at 448 reporting fertility clinics in the United States in 2017. These treatments resulted in 68,908 live births in the country, which led to the birth of 78,052 live born infants. Further, the report stated that the number of infants born in the United States using ART comprise of approximately 1.7% of all infants born in the region every year. The growing demand for these treatments is predicted to lead to an increased number of fertility clinics, thereby giving rise to the market growth.

In vitro Fertilization Market Share Graph
Get more information on this report: Request Free Sample PDF

Market Size and Forecast

The demand for in vitro fertilization has spiked in the last few years and is predicted to continue to rise as the number of IVF procedures are increasing globally. The in vitro fertilization market is anticipated to record a CAGR of around 10.3% over the forecast period, i.e., 2019-2027. The market is segmented by product, by end user and by region, out of which, the product segment is further divided into culture media, incubators, cryosystem, IVF cabinets and others. The culture media segment is anticipated to hold a significant share in the in vitro fertilization market on account of high government funding for the development of improved culture media. Moreover, the growth of this segment can be attributed to the rising research and development activities by both government and private research institutes.

In vitro Fertilization Market Share GraphOn the basis of end user, the market is segmented into hospitals, fertility clinics and others, out of which the fertility clinics segment is estimated to observe the highest growth over the forecast period. This can be attributed to the growing number of fertility clinics in various regions. As per the statistics collected by the Human Fertilisation and Embryology Authority, more than 1,100,000 IVF treatment cycles have taken place in UK licensed clinics between 1991 and 2016. The number of IVF treatment cycles is anticipated to further rise in the upcoming years.CLICK TO DOWNLOAD SAMPLE REPORT

IVF Treatment Cycles By Age Image



High Cost of IVF Procedure to Hamper the Market Growth

The in vitro fertilization treatment is a highly expensive procedure which restricts a large number of potential customer base from receiving the treatment. This is the major factor estimated to hinder the market growth. Additionally, the complications associated with IVF treatment, for instance, the risk of multiple births, are anticipated to limit the growth of this market further in the upcoming years.

Market Segmentation

Our in-depth analysis of the in vitro fertilization market includes the following segments:

By Product

  • Culture Media
  • Incubators
  • Cryosystem
  • IVF Cabinets 
  • Others

By End User

  • Hospitals
  • Fertility Clinics
  • Others

By Region

On the basis of regional analysis, the in vitro fertilization market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region.

The market for in vitro fertilization is anticipated to witness highest growth in Europe. The market in this region held the largest share in in vitro fertilization market in the year 2018. The considerable growth is on account of a larger demand for IVF procedures in the region along with advancements in technology which leads to the development of better techniques for IVF. Moreover, the Human Fertilisation and Embryology Authority estimated that in 2016, about 41% of IVF treatments that took place in UK were funded by the NHS. This funding has resulted in 65,730 births since 2008, with 8,507 births in the year 2016. The market in Asia Pacific is projected to grow at the highest rate over the forecast period as a result of growing awareness among people about the availability and convenience of assisted reproductive technology cycles. Further, the growing expenditure on healthcare and rising population of Asian countries, mainly China and India, are other factors estimated to increase the market growth in this region.

The in vitro fertilization market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC,  Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis.
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis

IVF Treatment Cycles By Age Image
Get more information on this report: Request Free Sample PDF

Top Featured Companies Dominating the Market

    • CARE Fertility
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis 
    • Vitrolife
    • LG Chem
    • Hunter Scientific Limited
    • Illumina, Inc.
    • Genea Biomedx
    • LabIVF Asia Pte Ltd.
    • IVF Store
    • Swerea AB
    • INVO Bioscience


In The News

  • On July 26, 2019, Vitrolife announced that it has collaborated with Prime Tech to develop as well as exclusively market the Piezo technique for improvement of Intracytoplasmic Sperm Injection (ICSI) procedure in human IVF treatment. The inclusion of Piezo technique in IVF would standardize and simplify the procedure.


Global Economic Impact

Request Insights
Despite Inflation & Fearing Recession, Businesses Across the Globe Expected to Do Better in 2023:

In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.

Author Credits:  Radhika Gupta, Shivam Bhutani

Let Us Hear About Your Requirements:

Submit Your Request For Proposal (RFP)

 Request Free Sample Copy